KPV
Also known as: Lysine-Proline-Valine · Alpha-MSH Fragment
A master anti-inflammatory tripeptide derived from alpha-MSH. Obliterates systemic inflammation at the genetic level without immunosuppression, making it a staple for IBD and gut health.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~30 minutes
200–500 mcg
Subcutaneous injection, oral, or topical
Mechanism of Action
Enters cells and inhibits NF-kB inflammatory signaling at the nuclear level, reducing TNF-alpha, IL-6, and other pro-inflammatory cytokines.
Key Research Areas
Frequently Asked Questions
What is KPV?▾
How does KPV work?▾
What is the recommended dosage for KPV?▾
What is the half-life of KPV?▾
Is KPV FDA approved?▾
Research Disclaimer
The information provided about KPV is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.